For: | Vos LJ, Janoski M, Wachowicz K, Yahya A, Boychak O, Amanie J, Pervez N, Parliament MB, Pituskin E, Fallone BG, Usmani N. Role of serial multiparametric magnetic resonance imaging in prostate cancer active surveillance. World J Radiol 2016; 8(4): 410-418 [PMID: 27158428 DOI: 10.4329/wjr.v8.i4.410] |
---|---|
URL: | https://www.wjgnet.com/1949-8470/full/v8/i4/410.htm |
Number | Citing Articles |
1 |
Esther Hendrika Johanna Hamoen, Caroline M.A. Hoeks, Diederik M. Somford, Inge M. van Oort, Henk Vergunst, Jorg R. Oddens, Geert A. Smits, Leonard P. Bokhorst, J. Alfred Witjes, Maroeska M. Rovers, Christina A. Hulsbergen-van de Kaa, Jelle O. Barentsz. Value of Serial Multiparametric Magnetic Resonance Imaging and Magnetic Resonance Imaging–guided Biopsies in Men with Low-risk Prostate Cancer on Active Surveillance After 1 Yr Follow-up. European Urology Focus 2019; 5(3): 407 doi: 10.1016/j.euf.2017.12.008
|
2 |
Francesco Cantiello, Giorgio Ivan Russo, Sascha Kaufmann, Giovanni Cacciamani, Fabio Crocerossa, Matteo Ferro, Ottavio De Cobelli, Walter Artibani, Sebastiano Cimino, Giuseppe Morgia, Rocco Damiano, Konstantin Nikolaou, Nils Kröger, Arnulf Stenzl, Jens Bedke, Stephan Kruck. Role of multiparametric magnetic resonance imaging for patients under active surveillance for prostate cancer: a systematic review with diagnostic meta-analysis. Prostate Cancer and Prostatic Diseases 2019; 22(2): 206 doi: 10.1038/s41391-018-0113-2
|
3 |
Sultan Zaher Alshehri, Omar Safar Alshahrani, Nazal Ahmed Almsaoud, Muhammad Ahmad Al-Ghamdi, Abdulaziz Mohammed Alqahtani, Muath Mohammed Almurayyi, Ali Salem Autwdi, Saeed Ahmed Al-Ghamdi, Mohammed Mesadef Zogan, Abdulrahim Mohammed Alamri. The role of multiparametric magnetic resonance imaging and magnetic resonance-guided biopsy in active surveillance for low-risk prostate cancer: A systematic review. Annals of Medicine and Surgery 2020; 57: 171 doi: 10.1016/j.amsu.2020.07.015
|
4 |
Tuomas Mirtti, Hanna Vasarainen, Antti Rannikko. Active Surveillance for Localized Prostate Cancer. Current Clinical Urology 2018; : 83 doi: 10.1007/978-3-319-62710-6_9
|
5 |
Olayemi Atinuke Alagbe, Antonio Carlos Westphalen, Valdair Francisco Muglia. The role of magnetic resonance imaging in active surveillance of prostate cancer. Radiologia Brasileira 2021; 54(4): 246 doi: 10.1590/0100-3984.2020.0069
|
6 |
Michael S. Leapman, Peter R. Carroll. What is the best way not to treat prostate cancer?. Urologic Oncology: Seminars and Original Investigations 2017; 35(2): 42 doi: 10.1016/j.urolonc.2016.09.003
|
7 |
Atsuko Fujihara, Tsuyoshi Iwata, Aliasger Shakir, Alessandro Tafuri, Giovanni E. Cacciamani, Karanvir Gill, Akbar Ashrafi, Osamu Ukimura, Mihir Desai, Vinay Duddalwar, Mariana S. Stern, Manju Aron, Suzanne L. Palmer, Inderbir S. Gill, Andre Luis Abreu. Multiparametric magnetic resonance imaging facilitates reclassification during active surveillance for prostate cancer. BJU International 2021; 127(6): 712 doi: 10.1111/bju.15272
|
8 |
Jared S. Winoker, Peter A. Pinto, Ardeshir R. Rastinehad. MRI to guide biopsies or avoid biopsies?. Current Opinion in Urology 2018; 28(6): 522 doi: 10.1097/MOU.0000000000000555
|
9 |
A. V. Vasilyev, A. V. Mishchenko, A. S. Petrova, A. K. Nosov, E. A. Busko, V. V. Danilov, E. Yu. Shevchenko. Modern Approach in Radiological Diagnosis of Prostate Cancer (Systematic Review of International Clinical Guidelines and Clinical Studies Over 2014–2020). Journal of radiology and nuclear medicine 2021; 101(6): 373 doi: 10.20862/0042-4676-2020-101-6-373-384
|
10 |
Pietro Pepe, Sebastiano Cimino, Antonio Garufi, Giandomenico Priolo, Giorgio Ivan Russo, Raimondo Giardina, Giulio Reale, Michele Pennisi, Giuseppe Morgia. Confirmatory biopsy of men under active surveillance: extended versus saturation versus multiparametric magnetic resonance imaging/transrectal ultrasound fusion prostate biopsy. Scandinavian Journal of Urology 2017; 51(4): 260 doi: 10.1080/21681805.2017.1313310
|
11 |
Kirema Garcia-Reyes, Hao G. Nguyen, Ronald J. Zagoria, Katsuto Shinohara, Peter R. Carroll, Spencer C. Behr, Antonio C. Westphalen. Impact of Lesion Visibility on Transrectal Ultrasound on the Prediction of Clinically Significant Prostate Cancer (Gleason Score 3 + 4 or Greater) with Transrectal Ultrasound-Magnetic Resonance Imaging Fusion Biopsy. Journal of Urology 2018; 199(3): 699 doi: 10.1016/j.juro.2017.09.075
|